FOXO1 activity plays a crucial role in the regulation of key genes involved in glucose and lipid metabolism, with dysregulation contributing to the development of MASLD (Ramadan et al., 2022). The gene discussed is FOXO1; the disease is metabolic dysfunction-associated steatotic liver disease.